Mississippi Announces Major Cannabis Rule Revisions
Mississippi's Department of Health has unveiled extensive revisions to cannabis industry regulations, seeking public input until Oct. 2.
The changes primarily focus on precise definitions of industry terms, including distinctions between cannabis and industrial hemp, classifications of various concentrates and refining definitions for medical cannabis establishments.
Additionally, new rules address advertising restrictions, business licensing, product testing, and safety, impacting the state's 370 licensed medical cannabis businesses, which encompass dispensaries, cultivators, transporters, processors, disposal entities and testing labs.
Studies Reveal Potential Contamination In East Coast Cannabis Market
Recent studies in Maine have raised concerns about potential contamination in the medical cannabis market, with indications that up to 50% of products may contain harmful substances, such as pesticides, microbes, yeast, and mold.
Unlike recreational cannabis products, medical cannabis in Maine is not subject to mandatory testing.
The Maine Office of Cannabis Policy has proposed implementing mandatory testing and a track-and-trace system, but it faces resistance from some industry members who argue it could be burdensome.
Meanwhile, in New York's legal cannabis industry, an investigative report by NY Cannabis Insider highlights significant public health issues, revealing that top-selling cannabis strains in licensed dispensaries across the state have microbial levels far exceeding allowable limits, potentially posing serious health threats.
Join us at the 17th edition of the Benzinga Cannabis Capital Conference in Chicago on September 27-28. Don't miss this opportunity to connect with industry leaders, investors, and innovative companies shaping the future of the cannabis industry. Get your tickets today before prices increase!
Pennsylvania Farm-To-Table Cannabis: Senate Advances Bill to Expand Access
The Pennsylvania Senate has passed Senate Bill 773, which would allow all licensed medical marijuana growers and processors in the state to directly sell their products to patients. Currently, only a limited number of license holders can act as dispensaries, leading to market concentration.
Lawmakers hope the bill will address this imbalance. The legislation may also open the door to further marijuana law reforms, including potential discussions on home cultivation and adult recreational use, signaling a growing momentum for marijuana reform in the state, reported Pennlive.
Seattle City Council Will Align Municipal Code With State Drug Possession Laws
The Seattle City Council voted 6-3 to align the city's municipal code with a 2023 state law that classifies public drug use and possession as a gross misdemeanor. This decision also grants the City Attorney's Office the authority to prosecute these crimes.
Supporters argue that the legislation is a necessary tool to address the drug crisis and encourage individuals with substance use disorders to seek treatment. Opponents view it as a return to failed Drug War tactics and anticipate it will disproportionately affect Black and brown residents.
Tobacco And Alcohol Heavyweights Team Up To Crush Illicit Cannabis Market
The Coalition for Cannabis Policy, Education, and Regulation (CPEAR), supported by tobacco and alcohol giants such as Altria MO, Reynolds American RAI, Molson Coors TAP and Constellation Brands STZ has released a report suggesting several policy recommendations to combat the illicit cannabis market in the U.S.
Recommendations include the establishment of a centralized nationwide track-and-trace system and introduction of marijuana tax stamps to differentiate regulated cannabis products and eliminate the illicit market, reported Ben Adlin for Marijuana Moment.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this September 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Frances Gunn on Unsplash.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.